Kapil SankarMeleveeduMDMBBS

Hematologic Oncology

Director, Blood and marrow transplant

Dr. Meleveedu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Kapil Sankar Meleveedu, based in Farmington, CT, specializes in Hematology with a subspecialty in Hematologic Oncology. He completed his residency in Internal Medicine at Bridgeport Hospital/Yale University between 2012 - 2015 and is a 2009 graduate of Calicut Medical College. Dr. Meleveedu has numerous publications in the field, covering topics related to Acute Myeloid Leukemia, Multiple Myeloma, and severe COVID-19 related illness, with some of his research being cited multiple times by other publications.

PubMed

Sequential Use of Prednisolone and Cyclosporine Is Effective in the Management of Immunotherapy-Related Hemolytic Anemia.
Cherian Verghese, Niravkumar Brahmbhatt, Ghulam Ghous, Kapil Meleveedu, Nancy Vander Velde
Journal of Hematology. 2024-12-01
1 citations
Acute myeloid leukemia in the medically unfit elderly patients.
Joseph Edmund, Liz Joemon Thaliath, Kapil Meleveedu
Leukemia Research. 2023-07-01
First case report of tumor lysis syndrome and acute renal failure after selinexor use in multiple myeloma.
Chrystina Castellon, Yashvin Onkarappa Mangala, Audrik Perez Rodriguez, Raymond Chaquette, Kapil Meleveedu
Leukemia & Lymphoma. 2021-08-09

Abstracts/Posters

Characteristics and Outcomes of Therapy Related Myeloid Neoplasms in Patients with Multiple Myeloma Following Autologous Stem Cell Transplantation
Kapil Meleveedu, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019